[Rheumatologic treatment in the G-DRG system]

Area of Science:

• Health economics
• Hospital reimbursement systems
• Rheumatology care

Background:

• Germany implemented a new inpatient hospital reimbursement system based on lump-sum payments in 2000.
• The German Diagnosis Related Groups (G-DRG) system was introduced to standardize hospital billing.
• Specialized rheumatology hospitals faced challenges with the initial G-DRG system (version 1.0).

Purpose of the Study:

• To evaluate the adequacy of the G-DRG system (version 1.0) for rheumatologic diagnostics and treatment.
• To identify specific challenges faced by specialized rheumatology hospitals within the G-DRG framework.
• To assess the impact of G-DRG system adaptations (version 2004) on rheumatologic care reimbursement.

Main Methods:

• A multi-center trial involving 7266 cases from 22 hospitals was conducted.
• Data analysis focused on case distribution across G-DRGs and length of stay.
• Comparison of rheumatologic patient stays with average lengths of stay used for G-DRG calculation.

Main Results:

• 91% of cases were covered by 7 Adjacent-DRGs, with 68% in just two DRGs (169 and 166).
• The G-DRG system (version 1.0) did not appropriately account for the complexity of rheumatologic cases.
• Rheumatology clinics experienced systematically longer lengths of stay than average G-DRG data, indicating inadequate reimbursement.

Conclusions:

• Accurate reimbursement for rheumatologic cases was not possible with G-DRG system 1.0.
• G-DRG version 2004 offers only partial solutions despite improved DRG construction.
• Adaptation of the G-DRG system for rheumatologic pathways or alternative reimbursement models are essential from 2005 onwards.